Search Results 131-140 of 2654 for < YEOTOP4 쩜 COM > 수락산오피✚수락산출장ざ수락산OP☐수락산키스방ಅ수락산오피♒수락산휴게텔❃수락산스파
The purpose of this study is to assess the long-term tolerability and safety of oral nintedanib treatment in patients with Progressive Fibrosing Interstitial ...
About this study. The purpose of this study is to evaluate dose escalation and expansion of MT-5111 (a recombinant fusion protein) in subjects with ...
HER2 1-3 + expression by IHC; OR · HER2 amplification by next generation sequencing panel (NGS) or in situ hybridization (ISH); OR · If local testing is not ...
Medical Departments & Centers ... amplification by FISH will be eligible to receive ... More about research at Mayo Clinic. Research Faculty · Laboratories · Core ...
More about research at Mayo Clinic. Research Faculty · Laboratories · Core Facilities · Centers & Programs · Departments & Divisions · Clinical Trials ...
The purpose of this study is to investigate the microbial, protein, genetic and cell profiles of the tracheal aspirates and amniotic fluid in human fetuses with ...
About this study. The primary objectives of this study are to determine the maximum tolerated dose/recommended phase 2 dose (MTD/RP2D) of selumetinib + ...
The primary objective of this study is to evaluate the safety and effectiveness of inhaled treprostinil in subjects with Idiopathic Pulmonary Fibrosis (IPF).
Faculty members conducting research in the Center for Multiple Sclerosis and Autoimmune Neurology at Mayo Clinic have wide-ranging expertise.
This study will evaluate the efficacy, safety, and tolerability of 2 doses of ubrogepant (25 and 50 mg) compared to placebo for the acute treatment of a single ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation can make a difference in the future of healthcare. Give now to support Mayo Clinic's research.